Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 6, 2013, Pages 470-474

  Zhou, Yi ^a   Hong, Liu ^b  

^a Union Medical Center   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; MICRORNA; MICRORNA 214; MIR 483; MULTIDRUG RESISTANCE PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; DRUG SENSITIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT PRECISION; MULTIDRUG RESISTANCE OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PREDICTION VALUE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; UPREGULATION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; P-GLYCOPROTEIN; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84878610925     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0518     Document Type: Article

References (18)

1. David S, Meltzer SJ (2011) MicroRNA involvement in esopha-geal carcinogenesis. Curr Opin Pharmacol 11:612-616.
2. Hao J, Zhang S, Zhou Y, et al. (2011) MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett 585:207-213.
3. Hong L, Han Y, Li S, et al. (2010a) The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas. Expert Opin Biol Ther 10:1693-1701.
4. Hong L, Han Y, Zhang H, et al. (2010b) The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 251:1056-1063.
5. Hong L, Li S, Han Y, et al. (2011) Angiogenesis-related molecular targets in esophageal cancer. Expert Opin Investig Drugs 20:637-644.
6. Hong L, Wang J, Han Y, et al. (2007) Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32. Cell Biol Int 31:1010-1015. (Pubitemid 46819074)
7. Huang SD, Yuan Y, Zhuang CW, et al. (2012) MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol Cancer 11:51.
8. Landau DA, Slack FJ (2011) MicroRNAs in mutagenesis, geno-mic instability, and DNA repair. Semin Oncol 38:743-751.
9. Majumder S, Jacob ST (2011) Emerging role of microRNAs in drug-resistant breast cancer. Gene Expr 15:141-151.
10. Patterson EE, Holloway AK, Weng J, et al. (2011) MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer 117:1630-1639.
11. Tsuchiya S, Fujiwara T, Sato F, et al. (2011) MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 286: 420-428.
12. van Mil A, Grundmann S, Goumans MJ, et al. (2012) MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc Res 93:655-665.
13. Veronese A, Lupini L, Consiglio J, et al. (2010) Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res 70:3140-3149.
14. Wang YS, Wang YH, Xia HP, et al. (2012) MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines. Asian Pac J Cancer Prev 13:255-260.
15. Yang H, Kong W, He L, et al. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68:425-433. (Pubitemid 351380068)
16. Yu ZW, Zhong LP, Ji T, Zhang P, et al. (2010) MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. Oral Oncol 46:317-322.
17. Zhang H, Li M, Han Y, et al. (2010a) Down-regulation of miR-27a might reverse multidrug resistance of esophageal squa-mous cell carcinoma. Dig Dis Sci 55:2545-2551.
18. Zhang XJ, Ye H, Zeng CW, et al. (2010b) Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol 3:46.